Biotech · Private company
Renibus Therapeutics, Inc.
Track this companyFree. Adds Renibus Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- RBT-1Phase 3 · Post-Operative Complications in Cardiac SurgeryClinicalTrials.gov · fetched Nov 12, 2026
- VeverimerPhase 3 · CKDClinicalTrials.gov · fetched Nov 12, 2026
- High Dose RBT-1Phase 2 · AKIClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose RBT-1Phase 2 · AKIClinicalTrials.gov · fetched Nov 12, 2026
- RBT-9 (90 mg)Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- RBT-1Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- RBT-3Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- RBT-9Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic AcidosisPHASE3 · RECRUITING · started Jan 13, 2026ClinicalTrials.gov NCT07355062 · fetched Nov 12, 2026
- Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve SurgeryACTIVE_NOT_RECRUITING · started Nov 18, 2023ClinicalTrials.gov NCT07009340 · fetched Nov 12, 2026
- Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac SurgeryPHASE3 · COMPLETED · started Oct 17, 2023ClinicalTrials.gov NCT06021457 · fetched Nov 12, 2026
- An Evaluation of Patient Reported Outcomes and Clinical OutcomesTERMINATED · started Oct 16, 2023ClinicalTrials.gov NCT06092970 · fetched Nov 12, 2026
- Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve SurgeryPHASE2 · COMPLETED · started Aug 4, 2021ClinicalTrials.gov NCT04564833 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)PHASE2 · TERMINATED · started Aug 5, 2020ClinicalTrials.gov NCT04364763 · fetched Nov 12, 2026
- A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney DiseasePHASE1 · COMPLETED · started Aug 27, 2019ClinicalTrials.gov NCT03893799 · fetched Nov 12, 2026
- A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney DiseasePHASE1 · COMPLETED · started Mar 31, 2019ClinicalTrials.gov NCT04072861 · fetched Nov 12, 2026
- A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney DiseasePHASE1 · COMPLETED · started Oct 21, 2018ClinicalTrials.gov NCT04072432 · fetched Nov 12, 2026